Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Leukemia. 2021 Jul;35(7):2108-2113. doi: 10.1038/s41375-020-01108-x. Epub 2020 Dec 17.

¹ Univ. Lille, CHU Lille, ULR 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France. franck.morchhauser@chru-lille.fr.
² Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, UK.
³ City of Hope National Medical Center, Duarte, CA, USA.
⁴ Département d'Hématologie IUCT-Oncopole, Toulouse, France.
⁵ WT-MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.
⁶ University Hospital of Wales, Cardiff, UK.
⁷ University of Plymouth Medical School, Plymouth, UK.
⁸ University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
⁹ Department of Clinical Hematology, University Hospital of Montpellier and UMR-CNRS 5535, Montpellier, France.
¹⁰ Hematology Clinic, University Hospital of Bordeaux, Pessac, France.
¹¹ Cancer Research UK Centre, University of Southampton, Southampton, UK.
¹² Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
¹³ Gilead Sciences, Inc, Foster City, CA, USA.
¹⁴ Hospices Civils de Lyon, Department of Hematology, Université de Lyon, Lyon, France.

No abstract available

Publication types